BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or "Company") announces that as a result of delays in the completion of its audit, the Company anticipates that it will experience a short-term delay ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

The Simplici-T ® Annuloplasty System offers a first-of-its-kind approach to mitral and tricuspid valve repair. It is the first flexible band to eliminate the need for traditional sizing ...

Companies on the 2024 Inc. 5000 are ranked according to percentage revenue growth over the last three years. They generated 874,940 jobs, $317 billion in revenue, and show where the economy is ...